Stabilization of peroxisome proliferator-activated receptor α by the ligand

被引:25
|
作者
Hirotani, M [1 ]
Tsukamoto, T [1 ]
Bourdeaux, J [1 ]
Sadano, H [1 ]
Osumi, T [1 ]
机构
[1] Himeji Inst Technol, Fac Sci, Dept Life Sci, Kamigori, Hyogo 6871297, Japan
关键词
peroxisome proliferator-activated receptor; retinoid X receptor; PPAR; RXR; ligand; nuclear hormone receptor;
D O I
10.1006/bbrc.2001.5739
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor (PPAR) constitutes a subfamily among a large group of ligand-activated transcription factors, the nuclear receptor superfamily. We studied the effects of ligand on the intracellular behaviors of PPAR alpha. Although nuclear localization of PPA-R alpha was not affected by a selective ligand, Wy14643, we observed that exogenously expressed PPARa alpha was rapidly degraded in HeLa cells, and the ligand significantly stabilized the protein. The stability of PPAR alpha was also improved by coexpression of the heterodimer partner retinoid X receptor (RXR) alpha, and further stabilization was not observed with the ligand. These results indicate that PPAR alpha is stabilized through heterodimerization with RXR, and the excess protein unpaired with RXR is rapidly turned over, if not bound by an appropriate ligand. These observations on PPAR alpha are in sharp contrast to the ligand-stimulated degradation reported on PPAR gamma. The ligand-dependent stabilization would have physiological significance when the synthesis of PPAR alpha is elevated exceeding the available level of RXR. (C) 2001 Academic Press.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 50 条
  • [1] Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor γ
    Gani, Osman A. B. S. M.
    Sylte, Ingebrigt
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (01) : 50 - 57
  • [2] Ligand selectivity of the peroxisome proliferator-activated receptor α
    Lin, QO
    Ruuska, SE
    Shaw, NS
    Dong, D
    Noy, N
    [J]. BIOCHEMISTRY, 1999, 38 (01) : 185 - 190
  • [3] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    [J]. GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [4] Nitrolinoleic acid:: An endogenous peroxisome proliferator-activated receptor γ ligand
    Schopfer, FJ
    Lin, YM
    Baker, PRS
    Cui, TX
    Garcia-Barrio, M
    Zhang, JF
    Chen, K
    Chen, YQE
    Freeman, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) : 2340 - 2345
  • [5] A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
    Oberfield, JL
    Collins, JL
    Holmes, CP
    Goreham, DM
    Cooper, JP
    Cobb, JE
    Lenhard, JM
    Hull-Ryde, EA
    Mohr, CP
    Blanchard, SG
    Parks, DJ
    Moore, LB
    Lehmann, JM
    Plunket, K
    Miller, AB
    Milburn, MV
    Kliewer, SA
    Willson, TM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) : 6102 - 6106
  • [6] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Marx, N
    [J]. CURRENT HYPERTENSION REPORTS, 2002, 4 (01) : 71 - 77
  • [7] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [8] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [9] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    [J]. PPAR RESEARCH, 2008, 2008
  • [10] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Nikolaus Marx
    [J]. Current Hypertension Reports, 2002, 4 : 71 - 77